Compounds having crth2 antagonist activity

Original document(41 pages) 中文版

Compounds of general formula (I) and their pharmaceutically acceptable salts, hydrates, solvates, complexes and prodrugs are useful in the treatment of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis.

Application Number 申请号	200480030071	Application Date 申请日	2004.10.13
Title 名称	Compounds having crth2 antagonist activity
Publication Number 公开号	1867547	Publication Date 公开日	2006.11.22
Approval Pub. Date		Granted Pub. Date
International Classification 分类号	C07D209/30,A61K31/404,A61P43/00,C07D403/12,C07D401/12,C07D417/12
Applicant(s) Name 申请人	Oxagen Ltd.
Address 地址
Inventor(s) Name 发明人	Middlemiss David, Ashton Mark Richard, Boyd Edward Andrew, Brookfield Frederick Arthur, Armer Richard Edward
Attorney & Agent 代理人	meng fanhong

Ethanolamine derivatives
Benzofuran derivatives
Method for the preparation of ethanolamine derivatives
Preparation of 3-azabicyclo [3.1.0] hexane derivatives
Cyclopropyl derivatives as NK3 receptor antagonists
Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders
Phenyl or pyridyl amide compounds as prostaglandin E2 antagonists
Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change
Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents
Piperazine with or-substituted phenyl group and their use as GLYT1 inhibitors

Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.